The proliferation and differentiation of human mast cells (MCs) occur under the influence of the mitogenic agent known as stem cell factor (SCF). This study analyses the distribution of SCF and SCF receptor in human myometrial tissue to further the understanding of the role(s) of MCs in the uterus. Immunohistochemical staining revealed that the majority of uterine MCs are located in close proximity to myometrial smooth muscle cells, and also among fibroblast-like spindle shaped cells. RNA extracts from myometrial tissues were subjected to reverse transcription. The resulting cDNA population was amplified by polymerase chain reaction (PCR) using a pair of 20-mer primers that were specific for SCF cDNA. Electrophoresis of the PCR products showed that the myometrial tissues contained transcripts for SCF. In-situ reverse transcription-PCR also revealed the expression of the transcripts for SCF in myometrial smooth muscle cells. Furthermore, enzyme-linked immunosorbent assays confirmed that the cultured myometrial cells produced SCF. Since immunohistochemical staining indicated there are SCF receptors on the surface of myometrial MCs, the results suggest that MC proliferation and differentiation in the myometrium is regulated by SCF secretion from the uterine smooth muscle cells. The mature MCs might, in turn, secrete mediators that influence tissue remodelling during the human menstrual cycle.
Introduction
cells (Zhang and Anthony, 1994) and Purkinje cells (Hirota et al., 1992) . In the human, it has been reported that there is Mast cells (MCs) arise from multi-potential haematopoietic a full-length mRNA for SCF, as well as a shorter transcript stem cells in the bone marrow. After partial differentiation, which lacks an 84 bp segment for exon 6 that encodes a precursor MCs are transported by the blood to various tissues cleavage message (Anderson et al., 1990, Flanagan et al. , where they proliferate and differentiate into mature MCs 1991). The translated protein from exon 6 represents the (Kitamura et al., 1987) . This proliferation and maturation site for proteolytic action which yields a soluble form of process occurs under the influence of certain growth factors SCF that can be released across the cell membrane (Williams and cytokines (Tsuji et al., 1991) . One such factor that appears et al., 1992) . That is to say, SCF can be transcribed and to be important for the differentiation of MCs is stem cell translated into a full-length factor that initially is membranefactor (SCF) (Zsebo et al., 1990 ). This factor is also known bound, but can be processed into a shorter, soluble form, or as steel factor (SLF) (Reith et al., 1991) , mast cell growth SCF can be produced as an exon 6-deficient factor that remains factor (MGF) (Anderson et al., 1990) , and kit ligand (KL) membrane bound. (Flanagan and Leder, 1990) . The latter term (KL) has been Some studies have reported that the soluble form of human used in some reports because there is evidence that SCF is a SCF is responsible for differentiation and maturation of the ligand for the proto-oncogene c-kit receptor (Flanagan and MC progenitor cells in vitro (Kirshenbaum et al., 1992; Mitsui Leder, 1990; Huang et al., 1990; Williams et al., 1990 Williams et al., ), et al., 1993 . However, other studies have focused on the and that activation of this membrane receptor induces MC importance of the membrane-bound form of SCF in MC differentiation from mononuclear cells of the bone marrow proliferation and differentiation. For example, it has been (Valent et al., 1992) , as well as from blood cells of the suggested that the membrane-bound form of SCF can act not umbilical cord (Mitsui et al., 1993) .
only as a growth factor, but also as a cell adhesion molecule In 1990, three different laboratories (Huang et al., 1990 ; (Flanagan et al., 1991) . Also, it has been reported that NIH/ Williams et al., 1990; Zsebo et al., 1990) succeeded in cloning 3T3 cells are able to maintain cultured murine MCs by means cDNAs of SCF. The expression of SCF mRNA has been of direct cell-cell interactions (Fujita et al., 1988a,b) . detected in a variety of tissues, including endothelial cells
In a previous report, we used immunohistological methods (Weiss et al., 1995) , bone marrow stromal cells (Aye et al., to show that the human uterus contains a substantial number of MCs, which are especially abundant in the inner half of the 1992), cytotrophoblasts (Saito et al., 1994) , endometrial stromal (i.e. for c-kit receptors). The tissue was placed initially in OCT myometrium (Mori et al., 1997) . MCs in myometrium have compound (Miles Laboratories, Elkhart, IN, USA) and then frozen also been reported to contain prostaglandin D 2 , leukotriene C 4 at -80°C. Immunohistochemistry was performed using the labelled and tumour necrosis factor α (TNFα) (Massey et al., 1991;  streptoavidin-biotin-immunoperoxidase technique (LSAB Kit; Roby and Hunt, 1995) . Since TNFα receptor mRNA has been Nichirei, Tokyo, Japan). Frozen sections were cut (6 µm thick) on identified in normal cycling and pregnant uteri, placentae, and a cryostat, air-dried, and fixed in acetone at 4°C for 10 min. After embryos (Tabibzadeh, 1994; Hunt et al., 1996) , MCs have rinsing the slides in PBS, endogenous peroxidase activity was blocked been suggested to play an important role in female reproduction by treating the tissue with 0.03% hydrogen peroxide in methanol for and embryonic development. However, the functional role(s) of 15 min. Then, the sections were exposed to 10% normal goat serum uterine MCs, and particularly their relationship to myometrial to minimize non-specific reactivity. Next, the sections were incubated smooth muscle cells, have not been fully characterized. Therewith affinity-purified anti-c-kit rabbit IgG (10 µg/ml; IBL, Fujioka, fore, in order to gain a better understanding of the nature of Japan) at 4°C overnight. After adequate rinsing with PBS, the tissue was stained as prescribed by the LSAB Kit and visualized with uterine MCs, the present study is a preliminary analysis of DAB. Sequential sections were treated with anti-tryptase monoclonal SCF in human myometrial tissue.
antibody to ascertain whether the SCF receptor-positive cells were MCs. In addition, some sections were treated with the immunoglobulin
Materials and methods
fraction of rabbit serum (Dako) as a negative control. The antibodies Experimental tissue used for immunohistochemistry or immunoassay in this study are commercially available and their specificity has been validated by Normal myometrial tissues were obtained from uteri of women who each supplier. had been diagnosed with leiomyoma. The tissues were used with the approval of the Ethical Committee of Shinshu University, Japan, and
Culturing myometrial tissue for analysis of SCF only after obtaining written consent from the patients. Our previous study in the human uterus revealed that there was no significant
The surgical specimens of myometrial tissue were rinsed in PBS and difference in the distribution and heterogeneity of mast cells between cut into small pieces. These pieces were transferred to Dulbecco's the myometrium from patients with leiomyoma and those with Modified Eagle's Medium (DMEM; Nissui Pharmaceutical, Tokyo, carcinoma in situ (CIS) of the cervix (Mori et al., 1997) . Therefore, for Japan) containing 10% fetal calf serum (FCS; Biological Industries, this experiment, we used myometrium from patients with leiomyoma.
Kibbutz Beth-Haemek, Israel), 1% antibiotic-antimycotic solution (Gibco BRL, Grand Island, NY, USA) and 0.1% collagenase (Wako Double-staining for smooth muscle cell and MC distribution Pure Chemical Industries, Osaka, Japan). Subsequently, the tissue in myometrial tissue was diced into smaller fragments~1-2 mm 3 , and incubated with The myometrial tissue was fixed in Carnoy's fixative overnight, and agitation at 37°C for 4 h. After this incubation period, the tissue was embedded in paraffin. The sections were incubated with 0.1% trypsin centrifuged at 400 r.p.m. for 5 min to sediment the non-dispersed in phospate-buffered saline (PBS) at 37°C for 30 min. Endogenous tissue. The supernatant fluid was re-centrifuged at 2000 r.p.m. for peroxidase activity was blocked by treating the tissue with 0.03% 20 min to pellet the dispersed cells. These cells were re-suspended hydrogen peroxide in methanol for 20 min. The sections were exposed in DMEM containing 10% FCS and incubated at 37°C in 5% CO 2 to 10% normal rabbit serum to minimize non-specific reactivity.
in air. Then, to detect smooth muscle cells, anti-α-smooth muscle actin After confluence of the primary culture, the cells were harvested monoclonal antibody (1:100 dilution; Dako, Glostrup, Denmark) was with 0.125% trypsin and 0.02% EDTA (pH 7.4) and grown as applied at 4°C overnight. After rinsing with PBS, the sections were second passage for reverse transcription-polymerase chain reactreated with peroxidase-conjugated anti-mouse immunoglobulin (Ig)G tion (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) (Amersham International; Amersham, Buckinghamshire, UK) at room analyses of SCF concentrations. temperature (RT) for 60 min. Subsequently, the antigen-containing smooth muscle cells were visualized by treating the sections with Confirmation of the phenotype of the cells in the primary 0.05% 3,3Ј-diaminobenzidine (DAB). To remove the primary antibody cultures and prepare the tissue for secondary staining, the sections were Prior to the RT-PCR and ELISA analyses, aliquots of the cells in washed twice with 0.1 M glycine-HCl buffer (pH 2.2) for 60 min.
the second passage were transferred to a microscopic slide by a It has been reported that tryptase is a specific marker for human Cytospin (Shandon, Pittsburgh, PA, USA), air-dried for 30 min, and tissue MCs (Schwartz, 1985; Hamann et al., 1994) . Therefore, to fixed in 95% ethanol for 5 min. Endogenous peroxidase activity was detect the presence of MCs in the myometrium, the sections were blocked by treating the cells with 0.03% hydrogen peroxide in exposed to anti-tryptase monoclonal antibody (0.2 µg/ml; Chemicon, methanol for 15 min. Then, the cells were treated with 10% normal Temecula, CA, USA) at RT for 60 min. After rinsing with 0.05 M rabbit serum to minimize non-specific reactivity. Next, the slides Tris-HCl (pH 7.4), the sections were exposed to anti-mouse IgG were incubated with anti-α-smooth muscle actin monoclonal antibody (Dako) at RT for 30 min. After rinsing again, the sections were (1:50 dilution; Dako) to detect smooth muscle cells, with anti-von exposed to an alkaline phosphatase-anti-alkaline phosphatase solution Willebrand factor antibody (1:50 dilution; Dako) to detect endothelial (Dako) for 30 min. Subsequently, the tryptase-positive MCs were cells, or with non-immune mouse serum (as a control) at 4°C visualized with naphthol AS-MX phosphate and Fast Red TR reagents.
overnight. After rinsing in PBS, the cells were treated with Following these treatments, cells containing α-smooth muscle actin peroxidase-conjugated anti-mouse IgG (Amersham) for 30 min and were stained brown, while the tryptase-positive MCs were stained visualized with DAB. Subsequently, the cells were counter-stained red. The sections were counter-stained with Mayer's haematoxylin.
with Mayer's haematoxylin. Cultured human T-cell leukaemia cells Immunohistochemical staining for the distribution of SCF were used as a negative control for von Willebrand factor and α-receptors smooth muscle actin. Frozen sections of endothelial tissue from the myometrium were used as a positive control for von The normal myometrial tissue that was obtained from the uteri of women diagnosed with leiomyoma was stained for SCF receptors Willebrand factor.
Extraction of total RNA from cultured cells In-situ RT-PCR amplification of SCF transcripts in myometrial tissue
Total RNA was extracted from myometrial tissue and cultured cells by the acid guanidinium-thiocyanate-phenol-chloroform method
To detect the localization of SCF mRNA in the myometrium, in-situ RT-PCR assay was performed according to the methods of Nuovo (Chomczynski and Sacchi, 1987) . The surgical specimens of myometrial tissue were prepared by the same technique used for et al. (1994) . Three frozen tissue sections (6 µm) were placed on a silane-coated slide, fixed in cold acetone for 10 min and stored at culture preparation. The dispersed cells of the myometrial tissue or the cultured myometrial cells were homogenized in 1 ml of Isogen Ϫ80°C. The tissue sections were fixed in 4% buffered paraformaldehyde for 20 min. After rinsing the sections in PBS and DEPC-(Nippon Gene, Tokyo, Japan). The homogenate was shaken vigorously for 60 s and stored at -80°C for 30 min. The frozen homogenate was water, the sections were incubated with 1 IU/µl DNase for 3 h at 37°C. After rinsing the sections in DEPC-water, reverse transcription incubated in a 37°C water bath for 5 min. Then, the sample was mixed with 0.1 ml of 24:1 mixture of chloroform/isoamyl alcohol mixture was placed on the sections and incubated at 42°C for 1 h. The reaction mixture contained 10 mM Tris-HCl (pH8.3), 50 mM and was shaken for 60 s, and placed on ice for 5 min. The sample was centrifuged at 14 000 r.p.m. at 4°C for 20 min. After KCl, 1.5 mM MgCl 2 , 25 µM dNTP mix, 1 mM dithiothreitol (DTT), 0.1 µM 3Ј-SCF primer, 0.4 IU/µl RNase inhibitor, 2.5 IU/µl MuLV centrifugation, the aqueous phase was transferred to a fresh tube, mixed with 300 µl of 24:1 mixture of chloroform/isoamyl alcohol reverse transcriptase (Perkin Elmer). After rinsing the sections in DEPC-water, the amplification step was carried out by applying 20 µl and 300 µl of phenol, and then the mixture was centrifuged at 14 000 r.p.m. at 4°C for 20 min. The aqueous phase was transferred of PCR reaction mixture containing 10 mM Tris-HCl (pH8.3), 50 mM KCl, 1.5 mM MgCl 2 , 1 mM DTT, 0.01% BSA, 50 µM each of dATP, to a fresh tube again, mixed with 600 µl of isopropanol, and then placed on ice for at least 20 min to precipitate RNA. After this dCTP, dGTP, 33 µM dTTP and17 µM digoxigenin-dUTP (Boehringer Mannheim, Indianapolis, IN, USA), 8.5 IU/100 µl of Taq DNA precipitation step, the mixture was centrifuged at 14 000 r.p.m. at 4°C for 20 min, the supernatant fluid was decanted, and the polymerase (Nippon Gene) and 1.7 µM of two 20-mer oligonucleotide primers. The primers were the same as that used in RT-PCR. The remaining RNA pellet was rinsed in 70% ethanol, centrifuged again, and the pellet was vacuum-dried for 5 min. Finally, this RNA pellet PCR reaction was performed with an initial denaturing step of 95°C for 10 min followed by 30 cycles of annealing at 55°C for 1 min, was dissolved in 10 mM Tris-HCl (pH 7.5), containing 1 mM EDTA, and used as the template for RT-PCR amplification.
extension at 72°C for 1 min and denaturation at 95°C for 1 min on a thermal cycler (Gene Amp in-situ PCR system 1000, Perkin Elmer).
RT-PCR amplification of SCF transcripts from cultured cells
The sections were washed twice in 5ϫ sodium chloride/sodium citrate (SSC), 2ϫ SSC, 1ϫ SSC, and 0.1ϫ SSC for 5 min at room The RT-PCR assay was performed with a Gene Amp RNA PCR Kit temperature. The digoxigenin-labelled cDNA segments were detected (Perkin Elmer, Foster City, CA, USA). The reverse transcription step by immunohistochemistry using alkaline phosphatase-conjugated antiwas performed by adding 1 µg of total RNA to 20 µl of a reaction digoxigenin Fab fragments (Boehringer Mannheim). The antibody mixture consisting of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 5 mM
(1:100 dilution) was applied to each sections at room temperature for MgCl 2 , 1 mM dNTP mixture, 1 IU/µl of RNase inhibitor, 2.5 IU/µl 1 h. Subsequently, an enzyme-catalysed colour reaction with 5-bromoof MuLV reverse transcriptase, and 2.5 µM of oligo-d(T) 16 primer.
4-chloro-3 indolyl phosphate and nitroblue terazolium salt (Boehringer The reverse transcription reaction was carried out at 42°C for 30 min, Mannheim) produced an insoluble blue precipitate that identified the stopped by heating at 99°C for 5 min, and then cooled at 5°C for amplified SCF cDNA molecules. The sections were not counter-5 min on a thermal cycler (Temp Control System PC-700; Astec, stained. The tissue section that was not digested with DNase and Fukuoka, Japan). The amplification step was carried out by adding treated with reverse transcriptase was used as a positive control. The 80 µl of PCR reaction mixture containing 10 mM Tris-HCl (pH 8.3), tissue section that was digested with DNase and not treated with 50 mM KCl, 2.5 IU/100 µl of AmpliTaq DNA polymerase, and reverse transcriptase was used as a negative control. The positive and 0.2 µM of two 20-mer oligonucleotide primers that were specific negative controls were performed on the same glass slide. for SCF.
The SCF primers were synthesized to encompass a segment of the Measurement of SCF in myometrial tissue cDNA sequence that included exon 6 (Aye et al., 1992) . On the sense Sections of myometrial tissue were rinsed in PBS, weighed, and strand, the primer was designed to complement nucleotides 324-343 homogenized in 2 ml of cell lysis buffer, consisting of 50 mM Tris-HCl (5Ј-GGATGACCTTGTGGAGTGCG-3Ј).
(pH 8.0), 0.25 M NaCl, 0.5% NP-40, 1 mM phenylmethanesulphonyl The antisense strand was complimentary to nucleotides 721-740 fluoride (Sigma, St Louis, MO, USA), 1 µg/ml aprotinin (Boehringer (5Ј-GCCCTTGTAAGACTTGGCTG-3Ј). The corresponding cDNA Mannheim), 1 µg/ml leupeptin (Boehringer), and 20 µg/ml N-tosylfragments were denatured at 94°C for 1 min, annealed at 58°C L-phenylalanine chloromethyl ketone (Boehringer). The lysates were for 1 min, and extended at 72°C for 1 min. After 30 cycles of centrifuged at 13 000 r.p.m. at 4°C for 20 min and the supernatants amplification, the PCR products were analysed on a 2% agarose gel were stored at -20°C until assayed for SCF. The amount of SCF was and the bands were visualized by ethidium bromide upon exposure determined in duplicate by an ELISA Kit (Amersham). The amount to a UV transilluminator. The nucleotide sequences of PCR products of SCF in the myometrial tissue was calculated by the formula: SCF were determined by dideoxynucleotide chain termination method concentration (pg/ml)ϫ2 ml/g wet weight. using DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA).
Measurement of SCF in the supernatant fluid of cultured As a positive control of SCF in RT-PCR, total RNA extracted cells from the endometrial tissue was used (Kauma et al., 1996) and as negative controls, total RNA extracted from T-cells was used (Aye After confluence in culture flasks (175 cm 2 ), the medium was decanted and the cultured cells were rinsed five times with PBS. Then, 28 ml et al., 1992) . Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an internal control for RNA. On the sense strand, the of fresh DBCM110 (Sigma) containing 0.1% FCS (pH 7.4) was added as described elsewhere (McKeehan et al., 1977) , and, immedi-GAPDH primer was designed as (5Ј-ACGACCACTTTGTCAA-GCTC-3Ј), and the antisense strand was designed as (5Ј-GGTCTAately, 3 ml of this medium was removed as a control sample. The remaining cells were incubated at 37°C in 5% CO 2 in air for 44 h. CATGGCAACTGTGA-3Ј). After this incubation period, a 3 ml sample of the medium was removed for SCF measurement. The medium was centrifuged at 2000 r.p.m. for 5 min to remove any particulate matter, and the supernatant fluid was stored at Ϫ20°C until assayed for SCF. At the same time, the viable cell count was determined in the samples.
The concentration of SCF in the samples was measured in duplicate using an ELISA Kit (Amersham). The assay is specific for SCF in the range of 31-2000 pg/ml. The amount of SCF in the medium was calculated by the formula: SCF concentration (pg/ml)ϫ25 ml/viable cell number (ϫ 10 6 cells).
Results

Double-staining for smooth muscle cells and MCs in myometrial tissue
To elucidate the distribution of MCs in the myometrial tissue, fibroblast-like spindle shaped cells.
Immunohistochemical staining for SCF receptor
remaining myometrial cells exhibited graded intensities of staining, following treatment with anti-α-smooth muscle actin Some sections of myometrial tissue were stained in order to assess the distribution of SCF receptors (Figure 2, arrow) . The
antibody. This staining procedure demonstrated that Ͼ90% of the cultured cells were smooth muscle cells. None of the SCF receptor-positive cells stained brown when treated with DAB. The positive cells were distributed in the myometrial human T-cell leukaemia cells that were used as a negative control stained positively following treatment with this tissue in a pattern comparable to MCs, and sequential sections that were stained for tryptase (which identifies MCs) indicated antibody. that the SCF receptors were located on the surface of MCs.
RT-PCR amplification of SCF transcripts from cultured cells Characterizing the phenotype of cultured myometrial cells
Following the reverse transcription reaction on RNA extracts from endometrial tissue (as a positive control), T-cells (as a In the preparations of cultured cells that were treated with anti-von Willebrand factor antibody to detect endothelial negative control), the myometrial tissue and cultured myometrial cells, PCR was performed using primers for sequences cells, Ͻ0.05% of the cell population stained positive. The flanking each side of exon 6 of SCF cDNA (Figure 3) . The be certain whether the SCF in sections of whole tissue was actually derived from myometrial cells, or whether it was a PCR products were resolved by electrophoresis on an agarose component of the blood serum supplying the uterine tissues. gel. Upon staining the gel with ethidium bromide, an intense However, SCF was detectable in the supernatant fluid of band of cDNA was observed at~416 bp, and a weaker band cultured myometrial cells that lacked the normal serum fraction. was present at~330 bp. The sequences of the cDNA were in Therefore, it appears that SCF may, indeed, be produced by agreement with the corresponding sequences of SCF. No bands the myometrial smooth muscle cells. It has been reported that were detected in the lane of T-cells (Figure 3 ). GAPDH cDNA SCF is produced also by cells lining cutaneous blood vessels bands (226 bp) amplified by RT-PCR were demonstrated in (Weiss et al., 1995) and by endothelial cells of human umbilical endometrial tissue, T-cells, the myometrial tissue and the veins (Aye et al., 1992) , so it was necessary to eliminate the cultured myometrial cells respectively. possibility that such vascular cells were the source of myoIn-situ RT-PCR amplification of SCF transcripts in metrial SCF. On the basis of the immunostaining for von myometrial tissue
Willebrand factor, the present study showed that there were very few endothelial cells among the cultured cells, and this In-situ RT-PCR in the myometrial tissue demonstrated blue observation suggests that the vast majority (Ͼ90%) of the staining that indicated SCF mRNA in nuclei, and these cells cultured cells were smooth muscle cells, along with perhaps were morphologically identical to smooth muscle cells. Almost a few fibroblasts. Therefore, it is concluded that smooth muscle all nuclei were stained in the positive control (Figure 4a) . cells are the principal source of myometrial SCF. Some of the endothelial cells were also stained blue (Figure 4b ).
Electrophoretic analysis of PCR products of SCF cDNA No staining was detected in the negative control (Figure 4c) .
showed an intensely stained band at~416 bp and a weaker Measurement of SCF in whole myometrial tissue and band at 330 bp. Since SCF mRNA is known to be expressed from cultured cells in two alternative forms, this data is consistent with the prediction that the primers selected for PCR would amplify ELISA assays of whole sections of the myometrium showed an SCF fragment that contained the nucleotide sequence for that this tissue contained 2271 Ϯ 923 (mean Ϯ SD) pg SCF/ exon 6, as well as a fragment that did not have exon 6. g wet weight (n ϭ 6). The SCF contents in the supernatant Consequently, SCF mRNA of both membrane-bound and fluid from four separate cultures of myometrial smooth muscle soluble form may be expressed in myometrial tissue and cells are shown in Table I . The mean value was 206.5 Ϯ 36.6 cultured myometrial cells. In addition, in-situ RT-PCR showed (mean Ϯ SD) pg/10 6 cells. SCF in the sample of control the expression of SCF mRNA in myometrial smooth muscle medium that was obtained before incubation of the cells was cells, which also suggests that smooth muscle cells in the below the level of sensitivity of the assay. myometrium produce SCF. The present findings are consistent with data from a pub-
Discussion
lished immunohistological study which showed that SCF In this study, the concentration of SCF in myometrial tissue protein is translated by myometrial smooth muscle cells was relatively high. Since the mean value of serum SCF is (Lammie et al., 1994) . However, in parallel experiments that were conducted during the present study, it was not possible also rather high (Langley et al., 1993) , it was not possible to a The amount of SCF was calculated by the formula: SCF concentration (pg/ml)ϫ25 ml/viable cell number (ϫ 10 6 cells).
However, it can be noted that the present data show that MCs are located in close proximity to the smooth muscle cells in the myometrium, and this observation is in keeping with the report that direct cell-cell interaction must exist between MCs and cells expressing SCF in order for MCs to be maintained in culture (Fujita et al., 1988a,b) . Therefore, taken together, these results provide a degree of support for the possibility that smooth muscle cells in the myometrium produce SCF.
The immunohistological data for the distribution of SCF receptors in the myometrium show that such receptors are localized on MCs. This observation is consistent with the findings of another laboratory (Horie et al., 1993) . Therefore, collectively, the results suggest that MC distribution in the myometrium is regulated by SCF from the uterine smooth muscle cells.
The data show that MCs are distributed in close proximity to smooth muscle cells in the myometrium. Since the bioactive agents in MCs are thought to have a paracrine effect on surrounding cells, the present observations suggest that smooth muscle cells are the most likely targets of MC mediators, but the specific action(s) of such mediators are not well understood. However, a functional relationship between MCs and fibroblasts, which are considered to be one of the targets of MC mediators, has already been established. For example, histamine (Jordana et al., 1988) , TNFα (Sugarman et al., 1985; Steffen et al., 1989) , and human MC tryptase (Ruoss et al., 1991) are mitogens for fibroblasts. Also, it has been reported that MC histamine enhances the production of collagen by fibroblasts (Hatamochi et al., 1985) . In contrast, tryptase (Krejci et al., 1992) and TNFα (Dayer et al., 1985) enhance collagenase production by fibroblasts and are responsible for in the proliferation of uterine smooth muscle cells by regulating formation of the extracellular matrix and influencing tissue remodelling. to detect immunohistochemical expression of SCF using other sources of monoclonal antibodies (Amgen, Thousand Oaks,
The concentration of MCs in the hamster uterus has been reported to vary during the reproductive cycle, with the lowest CA, USA) (Genzyme, Cambridge, MA, USA) and polyclonal antibodies (IBL) for this mitogenic factor (unpublished obsernumber of MCs being present on the fourth day of the cycle, shortly before ovulation (Brandon and Evans, 1983) . It has vations). Therefore, these negative results suggest that the production of SCF in myometrial smooth muscle cells may also been reported that the phase of the reproductive cycle, including embryo implantation influences the response of MCs be minimal.
